Your browser doesn't support javascript.
loading
Does REM sleep behavior disorder change in the progression of Parkinson's disease?
Figorilli, M; Marques, A R; Vidal, T; Delaby, L; Meloni, M; Pereira, B; Lambert, C; Puligheddu, M; Durif, F; Fantini, M L.
Afiliação
  • Figorilli M; EA 7280, UFR Medicine, University of Clermont Auvergne, Clermont-Ferrand, France; Sleep Disorder Center, Dept of Public Health & Clinical and Molecular Medicine. University of Cagliari, Italy.
  • Marques AR; EA 7280, UFR Medicine, University of Clermont Auvergne, Clermont-Ferrand, France; Neurology Department, CHU, Clermont-Ferrand, France.
  • Vidal T; CMRR, CHU, Clermont-Ferrand, France.
  • Delaby L; CMRR, CHU, Clermont-Ferrand, France.
  • Meloni M; Sleep Disorder Center, Dept of Public Health & Clinical and Molecular Medicine. University of Cagliari, Italy.
  • Pereira B; Biostatistics Unit (DRCI), CHU, Clermont-Ferrand, France.
  • Lambert C; Biostatistics Unit (DRCI), CHU, Clermont-Ferrand, France.
  • Puligheddu M; Sleep Disorder Center, Dept of Public Health & Clinical and Molecular Medicine. University of Cagliari, Italy.
  • Durif F; EA 7280, UFR Medicine, University of Clermont Auvergne, Clermont-Ferrand, France; Neurology Department, CHU, Clermont-Ferrand, France.
  • Fantini ML; EA 7280, UFR Medicine, University of Clermont Auvergne, Clermont-Ferrand, France; Neurology Department, CHU, Clermont-Ferrand, France. Electronic address: mfantini@chu-clermontferrand.fr.
Sleep Med ; 68: 190-198, 2020 04.
Article em En | MEDLINE | ID: mdl-32044557
ABSTRACT
OBJECTIVES/

BACKGROUND:

Rapid eye movement (REM) Sleep Behavior Disorder (RBD) in Parkinson's disease (PD) may be associated with a malignant phenotype. Despite its prognostic value, little is known about the time course of RBD in PD. In this study, we aimed to ascertain whether or not RBD is a stable feature in PD. In this study, we prospectively evaluated clinical and neurophysiological features of RBD, including REM Sleep Without Atonia (RSWA), in PD patients with RBD at baseline and after three years then assessed whether the changes in measures of RSWA parallel the progression of PD. PATIENTS/

METHODS:

In sum, 22 (17M, mean age 64.0 ± 6.9 years) moderate-to-advanced PD patients (mean PD duration at baseline7.6±4.8 years) with RBD, underwent a video-polysomnography (vPSG) recording and clinical and neuropsychological assessment at baseline and after three years.

RESULTS:

At follow-up, the self-assessed frequency of RBD symptoms increased in six patients, decreased in six and remained stable in 10, while RSWA measures significantly increased in all subjects. At follow-up, patients showed worse H&Y stage (p = 0.02), higher dopaminergic doses (p = 0.05) and they performed significantly worse in phonetic and semantic fluency tests (p = 0.02; p = 0.04). Changes in RSWA correlated significantly with the severity in levodopa-induced dyskinesia (r = 0.61,p = 0.05) and motor fluctuation (r = 0.54,p = 0.03) scores, and with the worsening of executive functions (r = 0.78,p = 0.001) and visuo-spatial perception (r = -0.57,p = 0.04).

CONCLUSION:

Despite the subjective improvement of RBD symptoms in one-fourth of PD patients, all RSWA measures increased significantly at follow-up, and their changes correlated with the clinical evolution of motor and non-motor symptoms. RBD is a long-lasting feature in PD and RSWA is a marker of the disease's progression.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Transtorno do Comportamento do Sono REM Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Transtorno do Comportamento do Sono REM Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article